NDC 59088-0905-54
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 59088-0905-54
- Product root
- 59088-0905
- Identity scope
- Package
- Primary current NDC product row
- Not present
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 59088-905 | 59088-905-54 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 59088-905 | 59088-905-54 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocan | LIDOCAINE 5% | PURETEK CORPORATION | fd8e4856-3785-4850-e053-6294a90a95b6 | 2026-01-27 | Warnings, Adverse reactions | 59088090554 |
| Xyliderm | LIDOCAINE, ISOPROPYL ALCOHOL | PureTek Corporation | fed45e06-cc4d-fbc5-e053-6294a90a1b19 | 2024-12-13 | Warnings, Adverse reactions | 59088090554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.